Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis

<table>Forest plot with the weighted mean difference (WMD) on daily living scale (ADL) of Hup A relative to placebo in AD with 95% CI of the trials included in meta-analysis.</table>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis 